The FDA has labeled Smiths Medical's recall of ProPort Implantable Plastic Port as Class I, the most serious kind.

The following is a summary of “Intraosseous versus intravenous vascular access in out-of-hospital cardiac arrest: a ...

BVT is a useful autologous procedure for hemodialysis and the preferred access alternative in patients without an adequate cephalic vein. Although patencies remain poor relative to other ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these ...

With 18 locations now serving the Chicago metro area, USA Vein Clinics has expanded access to expert vein care for suburban residents. This expansion reflects the clinic’s commitment to ...

[7] The main difficulty to an all-autologous approach is that patients who require hemodialysis access may not have adequate native veins to create a useful access. To improve compliance with ...